Yamaguchi et al. found that expression of FGFR1 increases with WHO grade in astrocytomas [39], and increased FGFR1 levels in GBM are not due to amplification of the FGFR1 gene [83]. This evidence concerns the gene FGFR1 and glioblastoma.